Clinical translation of nanomedicine
Clinical Translation of Nanomedicine | Chemical Reviews ACS ACS Publications C&EN CAS
Find my institution Log In Chemical Reviews ACS Publications. Most Trusted. Most Cited. Most …
Find my institution Log In Chemical Reviews ACS Publications. Most Trusted. Most Cited. Most …
Tumor angiogenesis and anti‑angiogenic gene therapy for cancer
T Li, G Kang, T Wang, HE Huang - Oncology letters, 2018 - spandidos-publications.com
When Folkman first suggested a theory about the association between angiogenesis and
tumor growth in 1971, the hypothesis of targeting angiogenesis to treat cancer was formed …
tumor growth in 1971, the hypothesis of targeting angiogenesis to treat cancer was formed …
Nanoparticle-mediated targeted drug delivery for breast cancer treatment
Breast cancer (BC) is the most common malignancy in women worldwide, and one of the
deadliest after lung cancer. Currently, standard methods for cancer therapy including BC are …
deadliest after lung cancer. Currently, standard methods for cancer therapy including BC are …
Nonviral vectors for gene delivery
MA Mintzer, EE Simanek - Chemical reviews, 2009 - ACS Publications
Gene therapy has gained significant attention over the past two decades as a potential
method for treating genetic disorders such as severe combined immunodeficiency, 1 cystic …
method for treating genetic disorders such as severe combined immunodeficiency, 1 cystic …
Drug delivery strategies for platinum-based chemotherapy
Few chemotherapeutics have had such an impact on cancer management as cis-
diamminedichloridoplatinum (II)(CDDP), also known as cisplatin. The first member of the …
diamminedichloridoplatinum (II)(CDDP), also known as cisplatin. The first member of the …
Nanoparticles-based drug delivery and gene therapy for breast cancer: Recent advancements and future challenges
Breast cancer (BC) is amongst the most lethal cancer among females and conventional
treatment methods like surgery, radiotherapy and chemotherapy are not effective enough as …
treatment methods like surgery, radiotherapy and chemotherapy are not effective enough as …
Ovarian cancer: strategies for overcoming resistance to chemotherapy
R Agarwal, SB Kaye - Nature Reviews Cancer, 2003 - nature.com
Ovarian cancer is responsible for 4% of deaths from cancer in women. Treatment comprises
a combination of surgery and chemotherapy, but patients typically experience disease …
a combination of surgery and chemotherapy, but patients typically experience disease …
Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer
Trastuzumab is a monoclonal antibody targeted against the human epidermal growth factor
receptor (HER) 2 tyrosine kinase receptor, which is overexpressed in approximately 25% of …
receptor (HER) 2 tyrosine kinase receptor, which is overexpressed in approximately 25% of …
Cationic nanocarriers induce cell necrosis through impairment of Na+/K+-ATPase and cause subsequent inflammatory response
Nanocarriers with positive surface charges are known for their toxicity which has limited their
clinical applications. The mechanism underlying their toxicity, such as the induction of …
clinical applications. The mechanism underlying their toxicity, such as the induction of …
Emerging use of nanoparticles in diagnosis and treatment of breast cancer
The biological application of nanoparticles is a rapidly developing area of nanotechnology
that raises new possibilities in the diagnosis and treatment of human cancers. In cancer …
that raises new possibilities in the diagnosis and treatment of human cancers. In cancer …